Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients

Yoshinori Miyazaki, Helen He, Lawrence J. Mandarino, Ralph A. DeFronzo

Research output: Contribution to journalArticlepeer-review

113 Scopus citations

Fingerprint

Dive into the research topics of 'Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients'. Together they form a unique fingerprint.

Medicine & Life Sciences